Reaktionsgleichung
[Br:1][C:2]1[CH:10]=[CH:9][C:5]([C:6](Cl)=[O:7])=[C:4]([F:11])[CH:3]=1.Cl.[CH3:13][C:14]1[C:15]([N:21]2[CH2:26][CH2:25][NH:24][CH2:23][CH2:22]2)=[N:16][CH:17]=[C:18]([CH3:20])[N:19]=1>>[Br:1][C:2]1[CH:10]=[CH:9][C:5]([C:6]([N:24]2[CH2:25][CH2:26][N:21]([C:15]3[C:14]([CH3:13])=[N:19][C:18]([CH3:20])=[CH:17][N:16]=3)[CH2:22][CH2:23]2)=[O:7])=[C:4]([F:11])[CH:3]=1Komponenten
3
Versuchsvorschrift
By reaction and treatment in the same manner as in Preparation Example 8 and using 4-bromo-2-fluorobenzoyl chloride (1.1 g) and 1-(3,5-dimethylpyrazin-2-yl)piperazine hydrochloride (915 mg) described in Preparation Example 59, the title compound (1.1 g) was obtained.
Aufarbeitung
- customBy reaction and treatment in the same manner
- customas in Preparation Example 8
- customdescribed in Preparation Example 59
Quellen und Nachweise
- ORD-Eintrag
- ord-4cd6e7e1f65a44afb88ec664acedf589
- Quelldatensatz
- uspto-grants-2013_01
- Patentnummer
- US08354401B2
Verknüpfte Notizen
Wird geladen…